"A 20th-round pick by Cleveland back in 2019, the righty made his way up the organizational ladder to reach Triple-A with excellent results in 2022. That seemingly put him on the radar for a call-up to the majors, but was diagnosed with Hodgkin Lymphoma in December of that year. The diagnosis came shortly after Enright was selected by the Marlins in the Rule 5 draft and severely limited him throughout the 2023 campaign, although he did eventually begin a rehab assignment while undergoing treatment."
"That earned Enright the opportunity to make his MLB debut this year, and he made the most of the opportunity with a sterling 2.03 ERA and a 23.7% strikeout rate in 31 innings of work. Enright had the look of a quality bullpen piece when on the mound, but his health derailed things once again when the righty underwent Tommy John surgery in October. The timing of that injury will cost Enright the entire 2026 season, which led the Guardians to non-tender him last month."
Nic Enright signed a two-year minor league deal with the Toronto Blue Jays for the 2026 and 2027 seasons. Enright rose from a 20th-round 2019 draft selection to Triple-A after strong 2022 results. He was diagnosed with Hodgkin lymphoma in December 2022, which limited his 2023 season despite beginning a rehab assignment during treatment. Enright returned to post strong minor-league results and made his MLB debut, recording a 2.03 ERA and a 23.7% strikeout rate in 31 innings. Tommy John surgery in October will sideline him for the 2026 season. The two-year contract allows the Blue Jays to oversee his rehab and retain control during recovery.
Read at MLB Trade Rumors
Unable to calculate read time
Collection
[
|
...
]